Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
1.185
-0.065 (-5.20%)
Mar 31, 2025, 11:33 AM EDT - Market open

Silo Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-4.39-3.7-3.913.9-3.04
Upgrade
Depreciation & Amortization
0.01----
Upgrade
Other Amortization
----0.27
Upgrade
Loss (Gain) From Sale of Investments
000.44-6.910.01
Upgrade
Stock-Based Compensation
-0.10.070.191.19
Upgrade
Provision & Write-off of Bad Debts
---0.02-0.150.17
Upgrade
Other Operating Activities
----0.020.34
Upgrade
Change in Accounts Payable
0.630.34-0.050.290.07
Upgrade
Change in Unearned Revenue
-0.07-0.07-0.070.48-
Upgrade
Change in Other Net Operating Assets
-0.010.030.05-0.04-0.14
Upgrade
Operating Cash Flow
-3.83-3.22-3.5-2.28-1.16
Upgrade
Investment in Securities
0.97-4.150.077.02-
Upgrade
Other Investing Activities
--0.020.170.04
Upgrade
Investing Cash Flow
0.97-4.150.097.190.04
Upgrade
Short-Term Debt Issued
---00.04
Upgrade
Long-Term Debt Issued
----0.02
Upgrade
Total Debt Issued
---00.05
Upgrade
Short-Term Debt Repaid
----0-0.04
Upgrade
Total Debt Repaid
----0-0.04
Upgrade
Net Debt Issued (Repaid)
----0.02
Upgrade
Issuance of Common Stock
3.41-4.94-2.12
Upgrade
Repurchase of Common Stock
-0.17-0.47---
Upgrade
Other Financing Activities
----0.48-
Upgrade
Financing Cash Flow
3.24-0.474.943.792.13
Upgrade
Net Cash Flow
0.38-7.841.538.711.02
Upgrade
Cash Interest Paid
-00-0
Upgrade
Cash Income Tax Paid
--0.03--
Upgrade
Levered Free Cash Flow
-2.07-1.78-2.24-1.10.16
Upgrade
Unlevered Free Cash Flow
-2.07-1.78-2.23-1.10.06
Upgrade
Change in Net Working Capital
-0.87-0.530.11-0.52-0.15
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q